Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Forte Biosciences (FBRX) Change in Accured Expenses (2016 - 2020)

Forte Biosciences (FBRX) has disclosed Change in Accured Expenses for 5 consecutive years, with $120000.0 as the latest value for Q4 2020.

  • Quarterly Change in Accured Expenses fell 24.05% to $120000.0 in Q4 2020 from the year-ago period, while the trailing twelve-month figure was -$3.2 million through Dec 2020, down 1276.1% year-over-year, with the annual reading at $8.4 million for FY2025, 7608.26% up from the prior year.
  • Change in Accured Expenses for Q4 2020 was $120000.0 at Forte Biosciences, up from $33000.0 in the prior quarter.
  • The five-year high for Change in Accured Expenses was $3.1 million in Q4 2018, with the low at -$3.7 million in Q2 2020.
  • Average Change in Accured Expenses over 5 years is $284650.0, with a median of $139000.0 recorded in 2019.
  • The sharpest move saw Change in Accured Expenses skyrocketed 2052.23% in 2018, then tumbled 847.78% in 2019.
  • Over 5 years, Change in Accured Expenses stood at $214000.0 in 2016, then plummeted by 173.36% to -$157000.0 in 2017, then surged by 2052.23% to $3.1 million in 2018, then tumbled by 94.85% to $158000.0 in 2019, then dropped by 24.05% to $120000.0 in 2020.
  • According to Business Quant data, Change in Accured Expenses over the past three periods came in at $120000.0, $33000.0, and -$3.7 million for Q4 2020, Q3 2020, and Q2 2020 respectively.